6CM
ONTXW icon

683 Capital Management’s Onconova Therapeutics, Inc. Warrants ONTXW Stock Holding History

683 Capital Management’s Portfolio ONTXW Stock Details ONTXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-922,550
Closed -$1.37M – 198
2018
Q3 		$1.37M Buy
+922,550
New +$148K 0.09% 93
2018
Q2 		– Sell
-2,000,000
Closed -$172K – 165
2018
Q1 		$172K Buy
+2,000,000
New +$749K 0.02% 121

Other funds holding ONTXW

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
TCP
Tyndall Capital Partners New York $452K AUM 26.52% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

683 Capital Management's ONTXW Position: Q4 2018 in Review

683 Capital Management sold out of Onconova Therapeutics, Inc. Warrants (ONTXW) in Q4 2018, closing a stake of 922,550 shares — an estimated $1.37M sold.

683 Capital Management first reported a position in ONTXW in Q1 2018 and held it in 2 quarters. The position peaked at $1.37M in Q3 2018. 4 funds tracked by Wall St. Rank hold ONTXW as of Q4 2018.

  • 683 Capital Management reported no remaining Onconova Therapeutics, Inc. Warrants position as of Q4 2018 after selling out during the quarter.
  • 683 Capital Management sold 922,550 Onconova Therapeutics, Inc. Warrants shares in Q4 2018, an estimated $1.37M.
  • 683 Capital Management first reported a position in Onconova Therapeutics, Inc. Warrants in Q1 2018 and held it in 2 quarters.
  • 683 Capital Management's Onconova Therapeutics, Inc. Warrants position peaked at $1.37M in Q3 2018.
  • 4 funds tracked by Wall St. Rank held Onconova Therapeutics, Inc. Warrants as of Q4 2018.

Based on 683 Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.